Problem: Decidual immune dysregulation is thought to underlie major pregnancy disorders; however, incomplete understanding of the decidual immune interface has hampered the mechanistic investigation.
| Flow cytometry and standardization
Isolated MCs were first labeled with LIVE/DEAD ® fixable blue stain 
| Data analysis
Manual analysis identifying well-characterized populations was performed using FlowJo v.10 software (FlowJo LLC, Ashland, OR, USA).
Dimensionality reduction was performed using the t-SNE algorithm, followed by DensVM clustering, both part of the open-source R package, Cytofkit (github.com/JinmiaoChenLab/cytofkit). 13 Briefly, data files were pre-gated to exclude dead cells and irrelevant populations and concatenated using FlowJo. Concatenated files were then uploaded to R/Cytofkit via GUI interface, and parameters of interest were selected. Newly derived t-SNE and DensVM coordinates were added to original data matrices, exported, and analyzed in FlowJo. Cluster frequencies and MFI values were then calculated within FlowJo. Heatmaps for MFI (z-score normalized) and cluster frequencies were constructed using JMP Pro ® v. 11.0.0 (SAS, Cary, NC, USA). All data are represented as mean ± SEM, and statistical significance was determined with ANOVA, followed by Tukey's post-hoc test to correct for multiple comparisons, using Prism ® v. 7 (GraphPad Software Inc, La Jolla, CA, USA). To examine the T-cell and dendritic cell component of the human term decidua, two 16-parameter panels (Table 1) were developed. These panels were validated by subset mapping of known T-cell subsets in human term decidua ( Figure 1 ) and technical control PBMCs (Fig.   S1 ). Similarly, diverse antigen-presenting cells were precisely defined (Figure 2 and Fig. S2 ), including macrophages (HLA-DR + CD16 − CD14 + , Figure 2B ), dendritic cells (DC, HLA-DR + CD16 − CD14 − , Figure 2C ), DC subsets plasmacytoid (pDCs, Figure 2D ), and myeloid (mDCs) type in human term decidua ( Figure 2E ).
| Cellular subset visualization by dimensionality reduction allows phenotype classification without complex gating
Analysis of flow cytometry data by manual methods can be a source of variation and requires expert knowledge. To test whether dimensionality reduction coupled with automated clustering presented (Table 2) , allowing rapid assignment of cell identity.
The t-SNE analysis pipeline was then used to classify decidual dendritic cells ( Figure 3C ), within HLA-DR + CD16 − subpopulations from three experiments (3 decidua basalis, 3 decidua parietalis, and 3 PBMC). Because a small subset of DCs express the CD14 marker, it was included in the analysis. DensVM analysis revealed 12 phenotype clusters on the merged t-SNE data set map ( Figure 3C , top). Major DC populations segregated onto unique regions of the generated t-SNE map ( Figure 3C, bottom) . MFI values for each marker were calculated for each cluster, and a heatmap was generated ( Figure 3D ). Thus, t-SNE/DensVM/CellOntology analysis pipeline provides an unbiased, operator-independent method for mapping the cellular immunome of the human decidua.
| DensVM clustering reveals unique immune signature of human term decidua
To determine whether patterns of cellular phenotypes observed in specimens constitute cellular "signatures" characteristic of tissue of origin (decidua, PBMC), individual t-SNE maps of decidual and PBMC specimens were visualized ( Figure 4A ). Quantification of phenotype were preferentially represented in PBMCs ( Figure 4C ).
To determine whether this was cell type specific, a similar analysis investigated the distribution of DC clusters in decidua and PBMCs Table 3) was significantly elevated in decidua parietalis, while clusters 6 and 8
(neutrophilic myelocyte) were elevated in PBMCs ( Figure 5C ).
| DISCUSSION
A successful pregnancy requires the collaboration of a diverse array of maternal and feto-placental immune and non-immune cells. Accordingly, the complex network of immune cells at the decidual maternal-fetal interface guides the assembly of tissue architecture and enacts an appropriate site-specific balance of immune privilege/tolerance and protection. Dysregulation of this system often leads to adverse consequences for both the mother and neonate. Historically, mechanistic dissection of these processes employed single/few identifying cellsurface markers to link specific immune cells with adverse pregnancy outcomes in humans 15, 16 and model systems, with mixed success, limiting translational/clinical progress. Consequently, the development and application of a novel, comprehensive, and unbiased analysis platform was necessary. We optimized and validated highly polychromatic flow cytometry to comprehensively and concomitantly examine the immune cells in term human decidua. Resulting data sets exhibited high dimensionality, and manual analysis confirmed and extended many known features of adaptive immunity found in the decidua, validating this approach. Analysis of such complex data sets, and standardization for future assessment of clinical-outcome-related cellular hubs, led us to apply operator-independent dimensionality reduction for visualization and machine learning algorithms for assignation of cellular identity.
To test the power of dimensionality reduction/machine learning analysis, and compare with manual expert gating, CD3 + cells from our specimens were analyzed. This revealed that among CD8 + T cells, the activated fraction is elevated, and naïve fraction is diminished in decidual tissues ( Figure 4C ). Furthermore, the identified cellular clusters defined the tissue-specific "cellular signature" as decidual specimens segregated from the control PBMCs when examined by Ward clustering. Previous studies have shown the presence of DCs at the maternal-fetal interface, 17, 18 and our data support those findings. However, the dramatic level of diversity within DC populations at the maternal-fetal interface has been underappreciated because most of these studies focused on a few defining markers. Dimensionality reduction analysis presented here revealed a high degree of diversity, with nine substantially unique clusters and distinctive DC subset distribution in the decidua ( Figure 5A,B) .
Herein, we demonstrate the power of t-SNE/DensVM analysis in classifying unique distributions of T/DC subtypes in decidual tissues.
The difficulties in the interpretation of clinically relevant data sets focused on immune cells at the maternal-fetal interface prompted the design of the current study to provide a nuanced understanding of the decidual immunome and establish a baseline for future studies in pregnancy pathology. Our experience reveals both the power and challenges of this approach. Utilization of high-dimensional flow cytometry is To reduce the technical variations between experiments, we employed use of bead standards to tune flow cytometer detectors prior to each run and employed automated specimen disaggregation, freezing, batching, and careful antibody batch titrations to increase staining consistency.
Despite these extensive efforts, we still observe batch effect when employing machine learning, indicating that even batch-batch staining difference not immediately apparent on manual 2D-section analysis will be revealed by agnostic learning algorithms (data not shown). This phenomenon is a key challenge in all of flow cytometry, and use of agreed-upon classifiers (such as CellOntology 14 ) can help curtail the batch variance.
Development of algorithms allowing efficient and operator-independent
cross-experiment normalization and classification is a key feature necessary for broader distribution of this technology. Similarly, seeding of t-SNE clusters and random-walk optimization is run-specific, necessitating rerunning of the entire concatenated series with each added specimen, a task that scales logarithmically with added data points, presenting challenges in computational time/resource use. We, and others, are currently pursuing optimizations and adaptations of dimensionality reduction/machine learning algorithms to overcome these limitations.
Accomplishing this goal would dramatically expand the use cases for flow cytometry/machine learning in clinical diagnostics. 
